Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-06-30 4:19 pm Purchase | 13D | Stoke Therapeutics Inc. STOK | Skorpios Trust | 14,443,681 39.3% | 14,443,681 (New Position) | View |
| 2021-06-28 8:54 pm Sale | 13D | Stoke Therapeutics Inc. STOK | ATP Life Science Ventures L.P. | 1,912,256 5.2% | -15,293,789 (-88.89%) | View |
| 2021-02-16 4:09 pm Purchase | 13G | Stoke Therapeutics Inc. STOK | Redmile Group LLC | 2,686,234 7.4% | 2,686,234 (New Position) | View |
| 2021-02-16 3:15 pm Sale | 13G | Stoke Therapeutics Inc. STOK | Cormorant Asset Management LP | 1,437,807 3.97% | -350,856 (-19.62%) | View |
| 2021-02-16 10:07 am Sale | 13G | Stoke Therapeutics Inc. STOK | GILDER GAGNON HOWE & CO LLC | 1,470,841 4.06% | -356,360 (-19.50%) | View |
| 2021-02-12 09:40 am Unchanged | 13G | Stoke Therapeutics Inc. STOK | RTW INVESTMENTS LP | 3,544,248 9.89% | 0 (Unchanged) | View |
| 2021-02-08 10:33 am Purchase | 13G | Stoke Therapeutics Inc. STOK | FMR LLC | 3,600,975 9.937% | 3,600,975 (New Position) | View |
| 2020-11-27 4:58 pm Purchase | 13D | Stoke Therapeutics Inc. STOK | ATP Life Science Ventures L.P. | 17,206,045 47.5% | 419,332 (+2.50%) | View |
| 2020-02-14 4:06 pm Sale | 13G | Stoke Therapeutics Inc. STOK | Cormorant Asset Management LP | 1,788,663 5.46% | -81,017 (-4.33%) | View |
| 2020-02-14 1:34 pm Purchase | 13G | Stoke Therapeutics Inc. STOK | RTW INVESTMENTS LP | 3,544,248 10.83% | 188,782 (+5.63%) | View |
| 2020-02-14 10:20 am Purchase | 13G | Stoke Therapeutics Inc. STOK | GILDER GAGNON HOWE & CO LLC | 1,827,201 5.58% | 1,827,201 (New Position) | View |
| 2019-07-01 4:10 pm Purchase | 13G | Stoke Therapeutics Inc. STOK | Cormorant Asset Management LP | 1,869,680 5.73% | 1,869,680 (New Position) | View |
| 2019-06-28 8:23 pm Purchase | 13D | Stoke Therapeutics Inc. STOK | ATP Life Science Ventures L.P. | 16,786,713 51.4% | 16,786,713 (New Position) | View |
| 2019-06-28 10:19 am Purchase | 13G | Stoke Therapeutics Inc. STOK | RTW INVESTMENTS LP | 3,355,466 10.67% | 3,355,466 (New Position) | View |